These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9717810

  • 1. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
    Lollini PL, Landuzzi L, Frabetti F, Rossi I, Nicoletti G, Scotlandi K, Serra M, Baldini N, De Giovanni C, Nanni P.
    Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z, Lafleur EA, Koshkina NV, Worth LL, Lester MS, Kleinerman ES.
    Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
    Kontny HU, Hämmerle K, Klein R, Shayan P, Mackall CL, Niemeyer CM.
    Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911
    [Abstract] [Full Text] [Related]

  • 4. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM, Westwood G, Selby PJ, Lewis IJ, Burchill SA.
    Cancer Res; 2000 Nov 01; 60(21):6160-70. PubMed ID: 11085540
    [Abstract] [Full Text] [Related]

  • 5. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N, Poulaki V, Mitsiades C, Tsokos M.
    Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151
    [Abstract] [Full Text] [Related]

  • 6. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
    Thomas DG, Giordano TJ, Sanders D, Biermann JS, Baker L.
    Clin Cancer Res; 2002 Mar 15; 8(3):788-93. PubMed ID: 11895910
    [Abstract] [Full Text] [Related]

  • 7. Plasminogen activators and their inhibitor in osteosarcomas and other bone tumors.
    Häkel C, Ueda Y, Tsuchya H, Herrera A, Blasius S, Roessner A.
    Zentralbl Pathol; 1994 Nov 15; 140(4-5):363-9. PubMed ID: 7826985
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
    Holt SV, Brookes KE, Dive C, Makin GW.
    Oncol Rep; 2011 Apr 15; 25(4):1177-81. PubMed ID: 21286665
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
    Scotlandi K, Manara MC, Nicoletti G, Lollini PL, Lukas S, Benini S, Croci S, Perdichizzi S, Zambelli D, Serra M, García-Echeverría C, Hofmann F, Picci P.
    Cancer Res; 2005 May 01; 65(9):3868-76. PubMed ID: 15867386
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.
    Garg V, Zhang W, Gidwani P, Kim M, Kolb EA.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5446-54. PubMed ID: 17875774
    [Abstract] [Full Text] [Related]

  • 13. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA, Hoffman AR, Otero J, Huang HY, Zhao Z, Mazumdar M, Gorlick R, Meyers P, Healey JH, Ladanyi M.
    Genes Chromosomes Cancer; 2004 Oct 15; 41(2):155-62. PubMed ID: 15287028
    [Abstract] [Full Text] [Related]

  • 14. Enhanced expression of PP1gamma1, a catalytic subunit isoform of protein phosphatase type1 and expression of telomerase activity in Ewing's sarcoma cells.
    Mori S, Cao Y, Yamadab T, Sogawa K, Kondo K, Hino N, Miyazaki T, Kawaguchi Y, Oka S, Kawasaki K, Mashiba T, Norimatsu H.
    Res Commun Mol Pathol Pharmacol; 2003 Oct 15; 113-114():269-74. PubMed ID: 15686125
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma.
    Kontny HU, Lehrnbecher TM, Chanock SJ, Mackall CL.
    Cancer Res; 1998 Dec 15; 58(24):5842-9. PubMed ID: 9865744
    [Abstract] [Full Text] [Related]

  • 16. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K, Tochigi N, Shimoda T, Yabe H, Morioka H, Toyama Y, Hosono A, Beppu Y, Kawai A, Hirohashi S, Kondo T.
    Clin Cancer Res; 2009 Apr 15; 15(8):2885-94. PubMed ID: 19351769
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 expression in pediatric sarcomas.
    Dickens DS, Kozielski R, Khan J, Forus A, Cripe TP.
    Pediatr Dev Pathol; 2002 Apr 15; 5(4):356-64. PubMed ID: 12024286
    [Abstract] [Full Text] [Related]

  • 18. Procollagens as markers for the cell of origin of human bone tumors.
    Stern R, Wilczek J, Thorpe WP, Rosenberg SA, Cannon G.
    Cancer Res; 1980 Feb 15; 40(2):325-8. PubMed ID: 6927962
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    Oncol Rep; 2005 Feb 15; 13(2):253-7. PubMed ID: 15643507
    [Abstract] [Full Text] [Related]

  • 20. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
    Halmos G, Schally AV, Bernardino AL, Varga JL.
    Int J Oncol; 2006 Aug 15; 29(2):463-9. PubMed ID: 16820890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.